Lexicon Pharmaceuticals, Inc.’s LXRX share price has dipped by 11.26%, which has investors questioning if this is right time ...

Leerink Partners analyst Roanna Ruiz has maintained their bullish stance on LXRX stock, giving a Buy rating yesterday.Invest with Confidence: ...

Needham analyst Joseph Stringer maintained a Hold rating on Lexicon Pharmaceuticals (LXRX – Research Report) today. The company’s shares closed ...

THE WOODLANDS, Texas, Jan. 21, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that the company will host a virtual webcast: “LX9211 - Changing the Paradigm for ...

Lexicon Pharmaceuticals Inc (LXRX) stock saw a decline, ending the day at $0.96 which represents a decrease of $-0.03 or -3.03% from the prior close of $0.99. The stock opened at $0.99 and touched a ...

Lexicon Pharmaceuticals Inc (LXRX) stock saw a modest uptick, ending the day at $0.99 which represents a slight increase of $0.10 or 11.24% from the prior close of $0.89. The stock opened at $0.97 and ...

Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that the company will host a virtual webcast: “LX9211 - Changing the Paradigm for Treatment of Neuropathic Pain.” The event will be ...

As discussion has renewed in the New Year around the Good Jobs Employment Rights Bill, one term has entered the lexicon: ...

LiquidPiston’s flagship innovation, the X-Engine, builds on the principles of rotary engines but with a transformative twist.

About two and a half years after originating the role of chief commercial officer at Arvinas, John Northcott is leaving his ...

Former president of Group One Limited joins the L-Acoustics team to spearhead North, Central, and South American operations ...

Senator Mitch McConnell (R-Ky.) has already fingered the most promising possibility—killing Biden Administration rules under ...